3,968 reports of this reaction
20.6% of all RIMEGEPANT SULFATE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for RIMEGEPANT SULFATE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 3,968 FDA adverse event reports linking RIMEGEPANT SULFATE to DRUG INEFFECTIVE. This represents approximately 20.6% of all 19,247 adverse event reports for this drug.
Patients taking RIMEGEPANT SULFATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for RIMEGEPANT SULFATE, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for RIMEGEPANT SULFATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 3,968 FDA reports for RIMEGEPANT SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 20.6% of all adverse event reports for RIMEGEPANT SULFATE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking RIMEGEPANT SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.